UNI-BIO GROUP: Signed a strategic cooperation agreement with SDKX to expand the global market for BoguTai®
I'm PortAI, I can summarize articles.
UNI-BIO GROUP has signed a strategic cooperation agreement with SDKX, authorizing SDKX to exclusively commercialize Bogu Tai® in six countries: Saudi Arabia, Egypt, Morocco, Colombia, Argentina, and Mexico. Since its launch in March 2024, the drug has performed exceptionally well, with expected revenue growth of 248.9% year-on-year in the first half of 2025. This cooperation provides a significant opportunity for Bogu Tai® to enter the market, with anticipated revenue by the end of 2026, supporting the group's globalization expansion strategy
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments